Sign inGet started

Baker Brian Lee

Insider CIK 1772399 · TPTX VP of Finance and Admin.

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TPTX Turning Point Therapeutics M Exercise deriv2021-03-232021-03-241,298— $00SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2021-03-232021-03-244,545— $06,494SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2021-03-232021-03-2411,904— $02,165SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2021-03-232021-03-2410,688— $019,668SEC↗
TPTX Turning Point Therapeutics M Exercise2021-03-232021-03-244,545$5.12 $23.3K21,863SEC↗
TPTX Turning Point Therapeutics M Exercise2021-03-232021-03-241,298$3.20 $4.2K17,318SEC↗
TPTX Turning Point Therapeutics M Exercise2021-03-232021-03-2410,688$7.43 $79.4K32,551SEC↗
TPTX Turning Point Therapeutics S Sale2021-03-232021-03-24100$104.17 $10.4K4,116SEC↗
TPTX Turning Point Therapeutics M Exercise2021-03-232021-03-2411,904$2.19 $26.1K16,020SEC↗
TPTX Turning Point Therapeutics S Sale2021-03-232021-03-241,996$100.07 $199.7K21,177SEC↗
TPTX Turning Point Therapeutics S Sale2021-03-232021-03-244,919$97.89 $481.5K27,632SEC↗
TPTX Turning Point Therapeutics S Sale2021-03-232021-03-244,459$98.76 $440.4K23,173SEC↗
TPTX Turning Point Therapeutics S Sale2021-03-232021-03-248,061$102.23 $824.1K8,106SEC↗
TPTX Turning Point Therapeutics S Sale2021-03-232021-03-243,890$102.84 $400.0K4,216SEC↗
TPTX Turning Point Therapeutics S Sale2021-03-232021-03-245,010$100.98 $505.9K16,167SEC↗
TPTX Turning Point Therapeutics A Award2021-03-222021-03-241,625— $04,116SEC↗
TPTX Turning Point Therapeutics A Award deriv2021-02-082021-02-106,675— $06,675SEC↗
TPTX Turning Point Therapeutics A Award2021-02-082021-02-101,483— $02,491SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2021-01-072021-01-0810,689— $030,356SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2021-01-072021-01-084,545— $011,039SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2021-01-072021-01-0811,905— $014,069SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2021-01-072021-01-081,299— $01,298SEC↗
TPTX Turning Point Therapeutics M Exercise2021-01-072021-01-084,545$5.12 $23.3K21,557SEC↗
TPTX Turning Point Therapeutics S Sale2021-01-072021-01-08900$120.16 $108.1K28,546SEC↗
TPTX Turning Point Therapeutics S Sale2021-01-072021-01-082,800$122.65 $343.4K29,446SEC↗
TPTX Turning Point Therapeutics M Exercise2021-01-072021-01-0810,689$7.43 $79.4K32,246SEC↗
TPTX Turning Point Therapeutics S Sale2021-01-072021-01-085,200$121.57 $632.2K23,346SEC↗
TPTX Turning Point Therapeutics M Exercise2021-01-072021-01-081,299$3.20 $4.2K17,012SEC↗
TPTX Turning Point Therapeutics M Exercise2021-01-072021-01-0811,905$2.19 $26.1K15,713SEC↗
TPTX Turning Point Therapeutics S Sale2021-01-072021-01-08513$123.02 $63.1K1,008SEC↗
TPTX Turning Point Therapeutics S Sale2021-01-072021-01-0821,825$122.44 $2.67M1,521SEC↗
TPTX Turning Point Therapeutics A Award deriv2020-01-062020-01-0850,000— $050,000SEC↗
TPTX Turning Point Therapeutics A Award2019-12-102020-01-08216$31.13 $6.7K3,016SEC↗
TPTX Turning Point Therapeutics P Buy2019-04-222019-04-242,800$18.00 $50.4K2,800SEC↗